Who owns SPRUCE BIOSCIENCES INC?
- Ticker: SPRB
- CUSIP Number: 85209e109
Tip: Access positions for across all investors
Analyze quarterly positions in Spruce Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Spruce Biosciences stock
Who bought or sold SPRUCE BIOSCIENCES INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
RiverVest Venture Management | 2.9M | $1.4B | 0% | Sep 2024 |
|
Carlyle | 2.9M | $1.2M | 0% | Dec 2024 |
|
Rock Springs Capital Management | 2.6M | $1.1M | 0% | Dec 2024 |
|
Acadian Asset Management | 1.0M | $437k | -17% | Dec 2024 |
|
Ikarian Capital | 1.0M | $420k | 100% | Dec 2024 |
|
Vanguard Group | 844k | $354k | 0% | Dec 2024 |
|
Sands Capital Ventures | 787k | $370k | 100% | Sep 2024 |
|
Renaissance Technologies | 406k | $171k | -33% | Dec 2024 |
|
ADAR1 Capital Management | 404k | $192k | 14% | Sep 2024 |
|
Boothbay Fund Management | 289k | $121k | 100% | Dec 2024 |
|
Geode Capital Management | 274k | $115k | 5% | Dec 2024 |
|
BlackRock | 125k | $52k | 0% | Dec 2024 |
|
UBS Group | 86k | $33k | 661785% | Dec 2024 |
|
Northern Trust | 80k | $34k | 7% | Dec 2024 |
|
Lion Point Capital | 75k | $32k | 0% | Dec 2024 |
|
State Street Corporation | 61k | $26k | -6% | Dec 2024 |
|
Susquehanna International | 59k | $25k | 307% | Dec 2024 |
|
Shay Capital | 38k | $18k | 189% | Sep 2024 |
|
Hrt Financial | 38k | $15k | 100% | Dec 2024 |
|
XTX Topco | 36k | $15k | 86% | Dec 2024 |
|
Bridgeway Capital Management | 35k | $15k | -13% | Dec 2024 |
|
Two Sigma Investments | 21k | $8.7k | -12% | Dec 2024 |
|
Two Sigma Advisers | 14k | $5.8k | -49% | Dec 2024 |
|
Simplex Trading | 4.9k | $2.0k | 100% | Dec 2024 |
|
Tower Research Capital | 4.8k | $2.0k | 2% | Dec 2024 |
|
Morgan Stanley | 2.1k | $895.860000 | 0% | Dec 2024 |
|
Group One Trading | 1.8k | $742.980000 | -54% | Dec 2024 |
|
Caldwell Sutter Capital | 1.0k | $420.000000 | 0% | Dec 2024 |
|
Bank of America Corporation | 222.00 | $92.995800 | 0% | Dec 2024 |
|
Bnp Paribas Arbitrage, Snc | 181.00 | $76.001900 | 100% | Dec 2024 |
|
Jpmorgan Chase & Co | 69.00 | $28.552200 | -3% | Dec 2024 |
|
Who sold out of Spruce Biosciences?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Altium Capital Management | Jun 2024 | 811k | $420k |
Almitas Capital | Sep 2024 | 397k | $188k |
Citadel Advisors | Sep 2024 | 80k | $38k |
Superstring Capital Management | Jun 2024 | 78k | $40k |
Privium Fund Management | Jun 2024 | 25k | $13k |
Jane Street | Sep 2024 | 16k | $7.4k |
Royal Bank of Canada | Sep 2024 | 3.7k | $2.0k |